Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by GAP Stage
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.